The role of epithelial-mesenchymal interactions in tissue repair, fibrogenesis and carcinogenesis

Current Signal Transduction Therapy

Volumn 2, Issue 3, 2007, Pages 214-220

  Do, D V ^a   Mukhopadhyay, A ^a   Lim, I J ^a   Phan, T T ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Extracellular matrix; Insulin like growth factor; Interleukin; Keloid derived fibroblasts; Matrix metalloproteinase

Indexed keywords

CANCER; CARCINOGENESIS; CELL INTERACTION; COCULTURE; EMBRYO DEVELOPMENT; EPITHELIUM; FIBROGENESIS; HOMEOSTASIS; HUMAN; HYPERTROPHIC SCAR; IN VITRO STUDY; IN VIVO STUDY; MAMMARY GLAND; MESENCHYME; MODEL; NONHUMAN; PARACRINE SIGNALING; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STROMA; TISSUE REPAIR; WOUND HEALING;

EID: 34848821877     PISSN: 15743624     EISSN: None     Source Type: Journal    
DOI: 10.2174/157436207781745346     Document Type: Review

References (71)

1. Mackezie IC. Epithelial-Mesenchymal interactions in the development and maintainance of epithelial tissues. In: The Keratinocytes Handbook. Cambridge University Press. 1994; 243-57.
2. Howlett AR, Bissell MJ. The influence of fissue microenvironment [stroma and extracellular matrix] on the development and function of mammary epithelium. Epithelial Cell Biol 1993; 2: 79-89.
3. Fusenig NE. Epithelial-mesenchymal interactions regulate keratinocyte growth and differentiation in vitro. In: The Keratinocyte Handbook. Cambridge University Press. 1994; 71-94.
4. Niessen FB, Andriessen MP, Schalkwijk J, Visser L, Timens W. Keratinocyte-derived growth factors play a role in the formation of hypertrophic scars. J Pathol 2001; 194: 207-16.
5. Lim IJ, Phan TT, Song C, Tan WT, Longaker MT. Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. Plast Reconstr Surg 2001; 107: 797-808.
6. Pinzani M, Rombouts K. Liver fibrosis, from the bench to clinical targets. Dig Liver Dis 2004; 36: 231-42.
7. Gauldie J, Kolb M, Sime PJ. A new direction in the pathogenesis of idiopathic pulmonary fibrosis? Respir Res 2002; 3: 1-8.
8. Ronnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast, Importance of the stromal reaction. Physiol Rev 1996; 76: 69125.
9. Arias AM. Epithelial mesenchymal interactions in cancer and development. Cell 2001; 105: 425-31.
10. Rheniwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes, the formation of keratinizing colonies from single cells. Cell 1975; 6: 331-343.
11. Katz AB, Taichman LB. Epidermis as a secretory tissue, an in-vitro tissue model to study keratinocyte secretion. J Invest Dermatol. 1994; 102: 55-60.
12. Bell E, Sher S, Hull B, et al. The reconstitution of living skin. J Invest Dermatol 1983; 81: 2s-10s.
13. Schmeichel KL, Bissell MJ. Modeling tissue-specific signaling and organ function in three dimensions. J Cell Sci 2003; 5: 2377-88.
14. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumour progression of initiated human prostatic epithelium. Cancer Res 1999; 59: 5002-11.
15. Stuelten CH, DaCosta Byfield S, Arany PR, Karpova TS, Steder-Stevenson WG, Roberts AB. Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta. J Cell Sci 2005; 118: 2143-53.
16. Escamez MJ, Garcia M, Larcher F, et al. An in vivo model of wound healing in genetically modified skin-humanized mice. J Invest Dermatol 2004; 123: 1182-91.
17. Barcellos-Hoff MH, Ravani SA. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 2000; 60: 1254:1260.
18. Kuperwasser C, Chavarria T, Wu M, et al. Reconstruction of functionally normal and malignant human breast tissue in mice. Proc Natl Acad Sci USA 2004; 101: 4966-4971.
19. Elenbaas B, Weinberg RA. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 2001; 264: 169-84.
20. Hsieh CL, Gardner TA, Miao L, Balian G, Chung LW. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells. Cancer Gene Ther 2004; 11: 148-55.
21. Ohuchida K, Mizumoto K, Murakami M, et al. Radiation to stromal fibroblasts increases invasiveness of pancreastic cancer cells through tumor-stromal interactions. Cancer Res 2004; 64: 1254-60.
22. Bhowmick NA, Chytil A, Plieth D, et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004; 303: 848-51.
23. Han G, Lu SL, Li AG, et al. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest 2005; 115: 1714-23.
24. Werner S, Peters KG, Longaker MT, Fuller-Pace F, Banda MJ, Williams LT. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci USA 1992; 89: 6896-900.
25. Nowinski D, Lysheden AS, Gardner H, Rubin K, Gerdin B, Ivarsson M. Analysis of gene expression in fibroblasts in response to keratinocyte-derived factors in vitro, potential implications for the wound healing process. J Invest Dermatol 2004; 122: 216-21.
26. Smola H, Thiekötter G, Fusenig NE. Mutual induction of growth factor gene expression by epidermal-dermal cell interaction. J Cell Biol 1993; 122: 417-429.
27. Smola H, Thiekötter G, Baur M, Stark HJ, Breitkreutz D, Fusenig NE. Organotypic and epidermal-dermal co-cultures of normal human keratinocytes and dermal cells, regulations of transforming growth factor alpha, beta1 and beta2 mRNA levels. Toxicol In Vitro 1994; 8: 641-650.
28. el-Ghalbzouri A, Gibbs S, Lamm E, Van Blitterswijk CA, Ponec M. Effect of fibroblasts on epidermal regeneration. Br J Dermatol 2002; 147: 230-243.
29. Smola H, Stark HJ, Thiekotter G, Mirancea N, Krieg T, Fusenig NE. Dynamics of basement membrane formation by keratinocyte fibroblast interactions in organotypic skin culture. Exp Cell Res 1998; 239: 399-410.
30. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83: 835-70.
31. Maas-Szabowski N, Shimotoyodome A, Fusenig NE. Keratinocyte growth regulation in fibroblast co-cultures via a double paracrine mechanism. J Cell Sci 1999; 112: 1843-1853.
32. Dinarello CA. Biologic basis for interleukin in disease. Blood 1996; 87: 2095-147.
33. Boxman IL, Ruwhof C, Boerman OC, Löwik CW, Ponec, M. Role of fibroblasts in the regulation of proinflammatory interteukin IL-1, IL-6 and IL-8 levels induced by keratinocyte-derived IL-1. Arch Dermatol Res 1996; 288: 391-98.
34. Maas-Szabowski N, Stark HJ, Fusenif NE. Keratinocyte growth regulation in defined organotypic cultures through IL-1 induced keratinocyte growth factor expression in resting fibroblast. J Invest Dermatol 2002; 114: 1075-84.
35. Kim IY, Kim MM, Kim SJ. Transforming growth factor-beta, biology and clinical relevance, J Biochem Mol Biol 2005; 38: 1-8.
36. Flanders KC. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 2004; 85: 47-64.
37. Yuan W, Varga J. Transforming growth factor repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. J Biol Chem 2001; 276: 38502-10.
38. Xia W, Phan TT, Lim IJ, Longaker MT, Yang GP. Complex epithelial-mesenchymal interactions modulate transforming growth factor-beta expression in keloid-derived cells. Wound Repair Regen 2004; 12: 546-56.
39. Bitterman PB, Henke CA. Fibroproliferative disorders. Chest 1991; 99: 81s-84s.
40. Ehrlich HP, Desmouli'ere A, Diegelmann RF, et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 1994; 145: 105-113.
41. Andriessen MP, Niessen FB, Van de Kerkhop PC, Schalkwijk J. Hypertrophic scarring is associated with epidermal abnormalities: an immunohistochemiscal study. J Pathol 1998; 186: 192-200.
42. Hakvoort TE, Altun V, Ramrattan RS, et al. Epidermal participation in post-burn hypertrophic scar development. Virchows Arch 1999; 434: 221-6.
43. Machesney M, Tidman N, Waseem A, Kirby L, Leigh I. Activated keratinocytes in the epidermis of hypertrophic scars. Am J Pathol 1998; 152: 1133-1141.
44. Moulin V. Growth factors in skin wound healing. Eur J Cell Biol 1995; 68: 1-7.
45. Heckmann M, Adelmann-Grill BC, Hein R, Krieg T. Biphasic effects of interleukin-1 alpha on dermal fibroblasts, enhancement of chemotactic responsiveness at low concentrations and of mRNA expression for collagenase at high concentrations. J Invest Dermatol 1993; 100: 780-784.
46. Niessen FB, Schalkwijk J, Vos H, Timens W. Hypertrophic seat formation is associated with an increased number of epidermal Langerhans cells. J Pathol 2004; 202: 121-9.
47. Bellemare J, Roberge CJ, Bergeron D, Lopez-Valle CA, Roy M, Moulin VJ. Epidermis promotes dermal fibrosis, role in the pathogenesis of hypertrophic scars. J Pathol 2005; 206: 1-8.
48. Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids, a review. Plast Reconstr Surg 1999; 104: 1435-1458.
49. Lim IJ, Phan TT, Bay BH, et al. Fibroblasts co-cultured with keloid keratinocytes, normal fibroblasts secrete collagen in a keloid like manner. Am J Physiol Cell Physiol 2002; 283: C212-22.
50. Funayama E, Chodon T, Oyama A, Sugihara T. Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts, an important role in the pathogenesis of keloid. J Invest Dermatol 2003; 121: 1326-31.
51. Phan TT, Lim IJ, Bay BH, et al. Role of IGF system of mitogens in the induction of fibroblast proliferation by keloid-derived keratinocytes in vitro. Am J Physiol Cell Physiol 2003; 284: C860-9.
52. Lim IJ, Phan TT, Tan EK, et al. Synchronous activation of ERK and phosphatidylinositol 3-kinase pathways is required for collagen and extracellular matrix production in keloids. J Biol Chem 2003; 278: 40851-8.
53. Mukhopadhyay A, Tan EK, Khoo YT, Chan SY, Lim IJ, Phan TT. Conditioned medium from keloid keratinocyte/keloid fibroblast co-culture induces contraction of fibroblast-populated collagen lattices. Br J Dermatol 2005; 152: 639-45.
54. Phan TT, Lim IJ, Aalami O, et al. Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions. J Pathol 2005; 20: 232-42.
55. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 643-649.
56. Bhowmick NA, Moses HL. Tumor-stroma interactions. Curr Opin Genet Dev 2005; 15: 97-101.
57. DeWever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003; 200: 429-47.
58. Micke P, Ostman A. Tumour-stroma interaction, cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 2004; 45: S163-75.
59. Hayward SW, Wang Y, Cao M, et al. Malignant transformation in a nontumorigenic human prostatic epithehial cell line. Cancer Res 2001; 61: 8135-42.
60. Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121: 335-48.
61. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y, Nakamura T. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells, in vitro analysis of tumor-stromal interactions. Cancer Res 1997; 57: 3305-13.
62. Pennachietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protoon-cogene. Cancer Cell 2003; 3: 347-361.
63. Matsumoto Y, Kataoka H, Date K, Nakamura T. Cooperative interaction between alpha-and beta-chains of hepatocyte growth factor on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses. J Biol Chem 1998; 273: 21920-2913.
64. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more, Nat Rev Mol Cell Biol 2003; 4: 915-25.
65. Roberts AB, Wakefield LM. The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci USA 2003; 100: 8621-3.
66. Cheng N, Bhowmick NA, Chytil A, et al. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene 2005; 24: 5053-68.
67. Peron CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-52.
68. Chang HY, Sneddon JB, Alizadeh AA, et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2004; 2: E7.
69. Chang HY, Nuyten DS, Sneddon JB, et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 2005; 102: 3738-43.
70. West RB, Nuyten DS, Subramanian S, et al. Determination of stromal signatures in breast carcinoma. PLoS Biol 2005; 3: e187.
71. Chung LW, Hsieh CL, Law A, et al. New targets for therapy in prostate cancer: modulation of stromal-epithelial interactions. Urology 2003; 6: 44-54.